Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy.
about
Neurotrophins and Neuropathic Pain: Role in PathobiologyNeurotoxicity in ovarian cancer patients on Gynecologic Oncology Group (GOG) protocol 218: characteristics associated with toxicity and the effect of substitution with docetaxel: an NRG Oncology/Gynecologic Oncology Group study.Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study.Chemotherapy-Induced Peripheral Neuropathy in Pediatric Cancer Patients.Profound and persistent painful paclitaxel peripheral neuropathy in a premenopausal patient.Retinoic acid reduces chemotherapy-induced neuropathy in an animal model and patients with lung cancer.Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma.Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention.Effect of Vitamin E on Oxaliplatin-induced Peripheral Neuropathy Prevention: A Randomized Controlled Trial.Nerve growth factor: from the early discoveries to the potential clinical useNerve growth factor alters microtubule targeting agent-induced neurotransmitter release but not MTA-induced neurite retraction in sensory neurons.Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy.Health-related quality of life in ovarian cancer patients and its impact on clinical managementSupportive care for women with gynecologic cancers.A systematic review of experimental and clinical acupuncture in chemotherapy-induced peripheral neuropathyPlatinum neurotoxicity pharmacogeneticsPathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN).Selected Risk Nutritional Factors for Chemotherapy-Induced PolyneuropathyDepletion of nerve growth factor in chemotherapy-induced peripheral neuropathy associated with hematologic malignanciesEarly, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy.Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity.Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy.Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients.Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale.Multi-center assessment of the Total Neuropathy Score for chemotherapy-induced peripheral neurotoxicity.Pain in cancer survivors.Chemotherapy-Induced Neuropathy
P2860
Q28084413-3006FDB2-1385-45FB-9635-81CAFB92BA3AQ30361070-956B8AC3-D6F2-407F-9AB9-D8B55CC3DB7EQ30818191-B0F21188-69C8-42D6-AB65-DC5A247FB444Q33889319-44EC1089-D75C-4676-9604-ABBB48F02376Q34303792-11B0493F-4A6D-4466-A653-086C688FA79FQ35210260-483D285F-7C99-48AC-9EF1-58912020B604Q36244607-B9D18820-0FF3-474F-840F-A92A8A2DFEB5Q36344699-418B29D4-554D-4857-9E57-18D7E1EE587DQ36350645-D3905C3D-4365-472F-A63B-04D683F20270Q36526946-6B1C90A3-8CFF-4B23-B9B8-5A9097FB6355Q36884527-1770D643-41A0-4F15-A5CF-A9009A4FCE1EQ36893299-4849A6F7-D8FB-4796-9C42-45113FAF28D8Q37036780-0D010964-0121-4CAF-B3F8-FCE1AC235AC8Q37086010-E045DE0B-D2E7-4735-9BCF-182077BCDAD7Q37091093-B9706247-8D04-4174-9CC2-1C485A54DC42Q37118862-2077F86A-92C8-4FF3-97AF-94D480CF32C3Q37399781-CA9CAD37-944B-402D-9D4F-EDB2F76D42BDQ38674146-3C99EB3D-3420-4C6E-8399-DA489923CC10Q41475920-F37ADB29-AB69-4209-A641-5E141EB490B3Q42750577-A47A3CB0-5A93-488E-8857-A10CF4574FC3Q43496569-1668B90F-D642-4B9E-93D6-2CFA4E50117AQ47552411-1C5FBAD1-7E63-477D-905A-D76440CB29B6Q50797877-5EE1FFB8-C386-445B-9C2F-2C1DE2635586Q51000217-3557FD8E-DA75-4658-ACBF-498F02575B59Q51939446-EB948FB7-2118-443E-8FB3-EBB422A44F9EQ54960570-E351C02C-3907-4C71-AA80-0ECF4BD67D5AQ58874394-22CEDD05-69A3-4F77-A13A-84657B8B00E9
P2860
Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Early predictors of peripheral ...... axel combination chemotherapy.
@en
Early predictors of peripheral ...... axel combination chemotherapy.
@nl
type
label
Early predictors of peripheral ...... axel combination chemotherapy.
@en
Early predictors of peripheral ...... axel combination chemotherapy.
@nl
prefLabel
Early predictors of peripheral ...... axel combination chemotherapy.
@en
Early predictors of peripheral ...... axel combination chemotherapy.
@nl
P2093
P356
P1433
P1476
Early predictors of peripheral ...... taxel combination chemotherapy
@en
P2093
L Marzorati
M T La Presa
P304
P356
10.1093/ANNONC/MDH348
P577
2004-09-01T00:00:00Z